The nitric oxide donor molsidomine prevents ischemia/reperfusion injury of the adult rat small intestine

Pediatric Surgery International

Volumn 19, Issue 4, 2003, Pages 305-308

  Öztürk, Hayrettin ^a   Aldemir, Mustafa ^a   Dokucu, Ali Ihsan ^a   Yaǧmur, Yusuf ^a   Kilinç, Nihal ^b   Şahin, Ahmet Hikmet ^a  

^a DICLE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b SSK Hospital   (Turkey)

Author keywords

Intestinal ischemia and reperfusion injury; Molsidomine; NG monomethyl L arginine

Indexed keywords

MALONALDEHYDE; MOLSIDOMINE; N(G) NITRO DEXTRO ARGININE METHYL ESTER; NITRIC OXIDE DONOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM; GASTROINTESTINAL MUCOSA; ILEUM; INTESTINE BLOOD FLOW; INTESTINE ISCHEMIA; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SMALL INTESTINE; TISSUE LEVEL;

ANIMALS; INTESTINAL MUCOSA; INTESTINE, SMALL; LIPID PEROXIDATION; MALONDIALDEHYDE; MOLSIDOMINE; RATS; RATS, SPRAGUE-DAWLEY; REGIONAL BLOOD FLOW; REPERFUSION INJURY; VASODILATOR AGENTS;

EID: 0037818313     PISSN: 01790358     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00383-002-0746-y     Document Type: Article

References (26)

1. Günel E, Çaǧlayan F, Çaǧlayan O, et al (1998) Treatment of intestinal reperfusion injury using antioxidative agents. J Pediatr Surg 33: 1536-1539
2. Takada K, Yamashita K, Sakurai-Yamashita Y, et al (1998) Participation of nitric oxide in the mucosal injury of rat intestine induced by ischemia-reperfusion. J PET 287: 403-407
3. Shah KA, Shurey S, Green CJ (1997) Apoptosis after intestinal ischemia-reperfusion injury. Transplantation 64: 1393-1397
4. Chen JC, Chen HM, Shyr MH, et al (2000) Selective inhibition of inducible nitric oxide in ischemia-reperfusion of rat small intestine. J Formos Med Assoc 99: 213-218
5. Zimmerman BJ, Granger DN (1992) Reperfusion injury. Surg Clin North Am 72: 65-83
6. Kukovetz WR, Holzmann S (1986) Cyclic GMP as the mediator of molsidomine-induced vasodilatation. Eur J Pharmacol 122: 130-109
7. Walder CE, Thiemermann C, Vane JR (1991) The involvement of endothelium-derived relaxing factor in the regulation of renal cortical blood flow in the rat. Br J Pharmacol 102: 967-973
8. Meigson SM, Horton JW, Chao HE, et al (1990) Prolonged survival and decreased mucosal injury after low-dose enteral allopurinol prophylaxis in mesenteric ischemia. J Pediatr Surg 25: 917-921
9. Yagi K (1994) Lipid peroxides in hepatic, gastrointestinal, and pancreatic diseases. In: Armstrong D (ed) Free radicals in diagnostic medicine. Plenum Press, New York, pp 165-169
10. Chiu CJ, Scott HJ, Gurd FN (1970) Intestinal mucosal lesion in low-flow states. II. The protective effect of intraluminal glucose as energy substrate. Arch Surg 101: 484-488
11. Mangino JE, Kotadia B, Mangino MJ (1996) Characterization of hypothermic intestinal ischemia-reperfusion injury in dogs. Effects of glycine. Transplantation 62: 173-178
12. Punch J, Rees R, Cashmer B, et al (1992) Xanthine oxidase: its role in no-reflow phenomenon. Surgery 111: 169-176
13. Koo A, Komatsu H, Tao G, et al (1993) Contribution of no-reflow phenomenon to hepatic injury after ischemia reperfusion: evidence for a role of superoxide anion. Hepatology 15: 507-514
14. Akgür FM, Olguner M, Yenici O, et al (1996) The effect of allopurinol pretreatment on intestinal hypoperfusion encountered after correction of intestinal volvulus. J Pediatr Surg 31: 1205-1207
15. Ruf W, Suehiro GT, Suehiro A, et al (1980) Intestinal blood flow at various intraluminal pressures in the piglet with closed abdomen. Ann Surg 191: 157-163
16. Caplan MS, Sun X-M, Hsueh W (1990) Hypoxia causes ischemic bowel necrosis in rats: the role of platelet-activating factor 8 (PAF-Acheter). Gastroenterology 99: 979-986
17. Czyrko C, Steigman C, Turley D, et al (1991) The role of reperfusion injury in occlusive intestinal ischemia of the neonate: malonaldehyde derived fluorescent products and correlation of histology. J Surg Res 51: 1-4
18. Otamiri TA (1988) Influence of quinacrine on plasma malondialdehyde after small intestinal ischemia and reperfusion. Circ Shock 24: 63-69
19. Durakbasa CU, Dagli TE, Mouni H, et al (1998) Nitric oxide and endothelin relationship in intestinal ischemia/reperfusion injury. Prostaglandins Leukot Essent Fatty Acids 59: 379-383
20. Reilly PM, Schiller HJ, Bulkley GB (1991) Pharmacologic approach to tissue injury mediated by free radicals and other active oxygen metabolites. Am J Surg 161: 488-503
21. Summers ST, Zinner MJ, Freischlag JA (1993) Production of endothelium-derived relaxing factor (EDRF) is compromised after ischemia and reperfusion. Am J Surg 166: 216-220
22. Davies MG, Hagen P-O (1993) The vascular endothelium: a new horizon. Ann Surg 218: 593-609
23. Kukovetz WR, Holzmann S (1985) Mechanism of vasodilation by molsidomine. Am Heart J 109: 637-640
24. Grisham MB, Hernandez LA, Granger DN (1986) Xanthine oxidase and neutrophil infiltration in intestinal ischemia. Am J Physiol 251: G567-574
25. Ward DT, Lawson SA, Gallagher CM, et al (2000) Sustained nitric oxide production via 1-arginine administration ameliorates effects of intestinal ischemia-reperfusion. J Surg Res 89: 13-19
26. Mc Call T, Whittle BJR, Boughton-Smith NK, et al (1988) Inhibition of fmlp-induced aggregation of rabbit neutrophils by nitric oxide. Br J Pharmacol 95: 517P